4 Biotechnology Stocks to Buy Now
News | 14 November 2012
The grades of four Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an ?A? (?strong buy?) or ?B? overall (?buy?) rating. This week, Incyte Corp. (NASDAQ:INCY) is showing significant ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
